Assessing the Relevance of Solution Phase Stress Testing of Solid Dosage Form Drug Products: A Cross-Industry Benchmarking Study

Campbell, John M.; Foti, Chris; Wang, Xiaoming; Adams, Neal; Allain, Leonardo R.; Araújo, Gabriela Tannus Branco de; Azevedo, Renan; Franca, Juçara Ribeiro; Hicks, Simon R.; Hostyn, Steven; Jansen, Patrick J.; Kotoni, Dorina; Kuemmell, A.; Marden, Stacey; Rullo, Gregory; Santos, Ana Cláudia O.; Sluggett, Gregory W.; Zelesky, Todd; Baertschi, Steven W.

doi:10.1016/j.xphs.2021.06.012

Cited by 5 publications

(2 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Making the design of these studies and interpretation of the results a complex activity. 6,7 Stress testing is often first initiated in Discovery (i.e., preclinical) and is typically repeated at least once during the clinical phase of development, in addition to excipient compatibility, and long-term DS and DP stability studies. 8,9 Due to the complexity of organic reaction chemistry and the diverse chemical environments pharmaceuticals experience, identifying the degradation mechanism(s), root causes, and control strategies is challenging.…”

Section: ■ Introductionmentioning

confidence: 99%

“…Determining the set of stress conditions and experimental execution specifics needed to induce the potential degradation pathways most relevant to pharmaceutical storage, distribution, and use requires consideration of several factors, not least, the physicochemical properties of the DS under study. Making the design of these studies and interpretation of the results a complex activity. , Stress testing is often first initiated in Discovery (i.e., preclinical) and is typically repeated at least once during the clinical phase of development, in addition to excipient compatibility, and long-term DS and DP stability studies. , …”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

In Silico Prediction of Pharmaceutical Degradation Pathways: A Benchmarking Study Using the Software Program Zeneth

Hemingway,

Baertschi,

Benstead

et al. 2024

Org. Process Res. Dev.

Self Cite

View full text Add to dashboard Cite

Zeneth, a software application for the prediction of chemical degradation of small organic molecules, incorporates a knowledge base of rules to predict degradation pathways. In addition, the knowledge base contains property predictors that modulate the predicted likelihood of a given degradation product. In this study, a C−H bond dissociation energy (C−H BDE) predictor, which has been integrated into the software, was utilized. To determine this software's predictive capabilities [using its knowledge base (2020.1.0 KB)], experimentally derived degradation profiles for 25 drug substances were compared to Zeneth predictions. These degradation profiles were derived from forced degradation studies, including accelerated and long-term stability studies, aligned with International Council for Harmonisation (ICH) guidelines. In addition, two case studies highlighting how prediction data can be utilized to confirm experimental data or assist with the identification of unknown degradation products have been presented. The specificity of prediction results was evaluated; transformation types that often predict degradation products not observed experimentally were identified, and an assessment of the causes is presented. The sensitivity for the study group was also evaluated using a historic knowledge base (2012.2.0 KB), enabling an assessment of how the predictive capabilities have improved over this period; the comparison demonstrated a 40% increase in sensitivity. This study has demonstrated that the ongoing expansion and optimization of this in silico tools knowledge base continues to result in improvements in its predictive capability and its ability to impart insight into the drug degradation knowledge space to aid pharmaceutical development.

show abstract

Section: ■ Introductionmentioning

confidence: 99%